来源：新浪证券-红岸工作室 期货概念+知识产权保护+跨境电商+创投+化肥 1、公司是弘业期货第二大股东,持股16.31%；弘业期货已在中国香港联交所主板上市。 2、公司控股子公司江苏爱涛文化产业有限公司参股江苏文化产权交易所有限公司，目前持有其28%的 股权。 3、根据2024年年报：依托亚马逊等平台开展出口零售，通过"HollyHOME""DOEWORKS"等自有品 牌，实现终端消费者直连，利润源自商品差价扣除成本及费用。 4、公司投资1200万持有江苏弘瑞科技投资公司24%的股份。弘瑞科技是江苏省第一家投向生物医药领 域创投公司（基金）。 5、子公司江苏省化肥工业有限公司注册的"苏化"牌肥料，在苏北拥有生产基地，产品广受农民好评。 公司广泛地为省内各氮肥、磷肥、复合肥生产企业提供生产原辅材料、备品备件及销售产品。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 8月27日，苏豪弘业涨0.09%，成交额1.95亿元，换手率7.19%，总市值26.82亿元。 异动分析 技术面：筹码平均交易成本为10.92元 该股筹码平均交易成本为10.92元，近期该股有吸筹现象，但 ...

8月20日，苏豪弘业涨0.00%，成交额7762.99万元，换手率2.89%，总市值26.95亿元。 异动分析 期货概念+知识产权保护+跨境电商+创投+化肥 1、公司是弘业期货第二大股东,持股16.31%；弘业期货已在中国香港联交所主板上市。 2、公司控股子公司江苏爱涛文化产业有限公司参股江苏文化产权交易所有限公司，目前持有其28%的 股权。 3、根据2024年年报：依托亚马逊等平台开展出口零售，通过"HollyHOME""DOEWORKS"等自有品 牌，实现终端消费者直连，利润源自商品差价扣除成本及费用。 4、公司投资1200万持有江苏弘瑞科技投资公司24%的股份。弘瑞科技是江苏省第一家投向生物医药领 域创投公司（基金）。 5、子公司江苏省化肥工业有限公司注册的"苏化"牌肥料，在苏北拥有生产基地，产品广受农民好评。 公司广泛地为省内各氮肥、磷肥、复合肥生产企业提供生产原辅材料、备品备件及销售产品。 来源：新浪证券-红岸工作室 区间今日近3日近5日近10日近20日主力净流入-878.88万-937.08万-1767.08万-1036.44万-6075.57万 主力持仓 主力没有控盘，筹码分布非常分散，主力成交 ...

Core Viewpoint - The company Suhao Hongye experienced a decline in stock price and has a market capitalization of 2.739 billion yuan, with significant trading activity noted on July 17 [1] Group 1: Company Overview - Suhao Hongye is located in Nanjing, Jiangsu Province, and was established on June 30, 1994, with its stock listed on September 1, 1997 [6] - The company's main business includes trade (import and export, domestic trade) and cultural activities (cultural engineering, art management, cultural venue operations, and cultural creative product development and sales) [6] - The revenue composition of the company is as follows: Energy and Chemicals 59.20%, Light Industry Crafts 21.52%, Mechanical and Electrical Products 9.28%, Others 7.37%, Cultural Engineering 2.64% [6] - As of March 31, the number of shareholders increased by 129.33% to 46,200, with an average of 5,339 circulating shares per person, a decrease of 56.39% [6] Group 2: Financial Performance - For the first quarter of 2025, the company achieved a revenue of 1.998 billion yuan, representing a year-on-year growth of 19.42%, and a net profit attributable to shareholders of 3.374 million yuan, up 11.08% year-on-year [6] - The company has distributed a total of 503 million yuan in dividends since its A-share listing, with 7.403 million yuan distributed in the last three years [7] Group 3: Investment and Subsidiaries - The company is the second-largest shareholder of Hongye Futures, holding 16.31% of its shares, which is listed on the Hong Kong Stock Exchange [2] - The company’s subsidiary, Jiangsu Aitao Cultural Industry Co., Ltd., holds a 28% stake in Jiangsu Cultural Property Exchange Co., Ltd. [2] - The company invested 12 million yuan for a 24% stake in Jiangsu Hongrui Technology Investment Co., Ltd., the first venture capital firm in Jiangsu Province focused on the biomedical field [2] Group 4: Market Activity - On July 17, the stock price of Suhao Hongye fell by 2.37%, with a trading volume of 210 million yuan and a turnover rate of 7.62% [1] - The main capital flow showed a net outflow of 27.6198 million yuan, with the industry ranking 13 out of 13, indicating unclear trends in main capital [3][4]